{"id":"W2750070121","doi":"10.1016/j.jval.2017.05.025","title":"Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Etanercept; Adalimumab; Dermatology Life Quality Index; Placebo; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Internal medicine; Randomized controlled trial; Erythema; Dermatology; Pathology; Disease; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02762405,0.003248785,0.01260114,0.00176304,0.0004845513,0.00286224,0.001862231,0.003347944,0.006560777],"category_scores_gemma":[0.0414983,0.001625392,0.01695123,0.001595323,0.00180307,0.00303442,0.001663442,0.004924237,0.0005232585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001538562,"about_ca_system_score_gemma":0.0008834527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001329868,"about_ca_topic_score_gemma":0.001557058,"domain_scores_codex":[0.9544926,0.03736121,0.003583757,0.002179202,0.001699754,0.0006835174],"domain_scores_gemma":[0.9373051,0.05012558,0.007214157,0.003066211,0.001314536,0.0009743682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8640986,0.0003633414,0.002968906,0.005595786,0.1170202,0.00005593609,0.00007484919,0.000958773,0.000377904,0.0003186105,0.0002606111,0.007906466],"study_design_scores_gemma":[0.7459961,0.03309165,0.01082495,0.001020103,0.2018391,0.000201579,0.000127124,0.00274119,0.0006681661,0.001903349,0.001468543,0.0001181902],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8279782,0.1465835,0.008773962,0.001378717,0.003202614,0.002871912,0.003838315,0.0001817676,0.005191053],"genre_scores_gemma":[0.982239,0.009810963,0.003494618,0.0006198256,0.0004725351,0.001210527,0.00111745,0.00004258713,0.0009924637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02762405,"threshold_uncertainty_score":0.1460917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3768532601695033,"score_gpt":0.4339955981307294,"score_spread":0.05714233796122609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}